Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial

被引：1
|
作者：
Andreassen, A. K. [1 ]
Andersson, B. [2 ]
Gustafsson, F. [3 ]
Eiskjaer, H. [4 ]
Radegran, G. [5 ,6 ]
Gude, E. [1 ]
Jansson, K. [7 ,8 ]
Solbu, D. [9 ]
Karason, K. [2 ]
Arora, S. [1 ]
Dellgren, G. [10 ]
Gullestad, I. [1 ]
机构：
[1] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[3] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark
[5] Skane Univ Hosp, Dept Cardiol, Clin Heart Failure & Valvular Dis, Lund, Sweden
[6] Lund Univ, Lund, Sweden
[7] Cty Council Ostergotland, Dept Cardiol, Heart & Med Ctr, Linkoping, Sweden
[8] Linkoping Univ, Linkoping, Sweden
[9] Novartis Norge AS, Oslo, Norway
[10] Sahlgrens Univ Hosp, Transplant Inst, Gothenburg, Sweden
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2015年 / 34卷 / 04期
关键词：
D O I：
10.1016/j.healun.2015.01.346
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
332
引用
收藏
页码：S129 / S130
页数：2
相关论文
共 50 条
  • [21] The Effect of Everolimus vs Calcineurin Inhibitors on Left Ventricular Mass in De Novo Heart Transplant Recipients After 3 Years Follow-Up - Results From the Randomized Controlled SCHEDULE Trial
    Murbraech, K.
    Massey, R.
    Karason, K.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Solbu, D.
    Broch, K.
    Gude, E.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S416 - S416
  • [22] Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
    Authen, Anne Relbo
    Grov, Ingelin
    Karason, Kristjan
    Gustafsson, Finn
    Eiskjaer, Hans
    Radegran, Goran
    Gude, Einar
    Jansson, Kjell
    Dellgren, Goran
    Solbu, Dag
    Arora, Satish
    Andreassen, Arne K.
    Gullestad, Lars
    [J]. CLINICAL TRANSPLANTATION, 2017, 31 (09)
  • [23] Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance (Schedule): Results After 6 Years of Follow-up
    Andreassen, A. K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S18 - S18
  • [24] Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
    Sterneck, M.
    Kaiser, G. M.
    Heyne, N.
    Richter, N.
    Rauchfuss, F.
    Pascher, A.
    Schemmer, P.
    Fischer, L.
    Klein, C. G.
    Nadalin, S.
    Lehner, F.
    Settmacher, U.
    Neuhaus, P.
    Gotthardt, D.
    Loss, M.
    Ladenburger, S.
    Paulus, E. M.
    Mertens, M.
    Schlitt, H. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (03) : 701 - 710
  • [25] RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 2 YEAR FOLLOW-UP DATA OF THE APOLLO TRIAL
    Sommerer, Claudia
    Rath, Thomas
    Budde, Klemens
    Haller, Hermann
    Arns, Wolfgang
    Scheidl, Stefan
    Vogel, Eva-Maria
    Witzke, Oliver
    Reinke, Petra
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 180
  • [26] RENAL FUNCTION, EFFICACY AND SAFETY OF SIROLIMUS AND MYCOPHENOLAT MOFETIL THERAPY AFTER EARLY CALCINEURIN-INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: ONE-YEAR ANALYSIS OF A RANDOMIZED MULTICENTER TRIAL
    Guba, Markus
    Pratschke, Johann
    Hugo, Christian
    Kraemer, Bernhard
    Nohr-Westphal, Constanze
    Brockmann, Jens
    Jauch, Karl-Walter
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 78 - 78
  • [27] Effect of Everolimus on Left Ventricular Hypertrophy of De Novo Kidney Transplant Recipients: A 1 Year, Randomized, Controlled Trial
    Paoletti, Ernesto
    Marsano, Luigina
    Bellino, Diego
    Cassottana, Paolo
    Cannella, Giuseppe
    [J]. TRANSPLANTATION, 2012, 93 (05) : 503 - 508
  • [28] Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial
    Andreassen, Arne K.
    Broch, Kaspar
    Eiskjaer, Hans
    Karason, Kristjan
    Gude, Einar
    Molbak, Dorte
    Stueflotten, Wenche
    Gullestad, Lars
    [J]. TRANSPLANTATION, 2019, 103 (04) : 781 - 788
  • [29] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy Assessed by Virtual Histology: Results of the SCHEDULE Trial
    Arora, S.
    Solberg, O.
    Gustafsson, F.
    Karason, K.
    Eiskjaer, H.
    Botker, H. E.
    Radegran, G.
    Dellgren, G.
    Ioanes, D.
    Gude, E.
    Solbu, D.
    Andreassen, A. K.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S16 - S17
  • [30] Immunogenicity of pneumococcal vaccine in renal transplant recipients - Three year follow-up of a randomized trial
    Kumar, D.
    Welsh, B.
    Siegal, D.
    chen, M. Hong
    Humar, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (03) : 633 - 638
12345